InvestorsHub Logo
Followers 13
Posts 4329
Boards Moderated 0
Alias Born 10/27/2020

Re: None

Monday, 11/16/2020 7:02:55 PM

Monday, November 16, 2020 7:02:55 PM

Post# of 18220
Immune Therapeutics, Inc. (OTC Pink: IMUN) ("Immune" "IMUN" or the "Company") is a late-stage biopharmaceutical company focused on the development of T-cell activation immunotherapy to treat life-threatening or chronic diseases announced it has initiated a corporate plan to drive shareholder value.Recent economic events require that Immune revisit its business model and explore new opportunities to drive shareholder value.$IMUN